advertisement
Nakamura N 11
Showing records 1 to 11 | Display all abstracts from Nakamura N94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Sakata R
Japanese Journal of Ophthalmology 2021; 65: 591-597
95517 Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death
Nakamura N; Honjo M
Experimental Eye Research 2021; 208: 108623
94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Fujishiro T; Saito H
Japanese Journal of Ophthalmology 2021; 65: 591-597
95517 Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death
Yamagishi R
Experimental Eye Research 2021; 208: 108623
94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Nakamura N
Japanese Journal of Ophthalmology 2021; 65: 591-597
95517 Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death
Kurano M; Yatomi Y
Experimental Eye Research 2021; 208: 108623
94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Honjo M
Japanese Journal of Ophthalmology 2021; 65: 591-597
95517 Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death
Watanabe S
Experimental Eye Research 2021; 208: 108623
94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Shirato S; Miyamoto E
Japanese Journal of Ophthalmology 2021; 65: 591-597
95517 Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death
Aihara M
Experimental Eye Research 2021; 208: 108623
94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Yamada Y; Aihara M
Japanese Journal of Ophthalmology 2021; 65: 591-597
